Please assess the completion status of the following clinical trial:

Trial Title: REFRESH: Receptivity Enhancement by Follicular-phase Renewal After Endometrial ScratcHing

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Fresh IVF/ICSI cycle~* Antagonist down-regulation~* Signed informed consent~Exclusion Criteria:~* Other known reasons for impaired implantation (i.e. hydrosalpinx, fibroid distorting the endometrial cavity, Asherman's syndrome, thrombophilia or endometrial tuberculosis)~* Oocyte donation acceptors~* Frozen egg transfers~* Embryos planned to undergo preimplantation genetic diagnosis (PGD)~* BMI \>35 or \<18~* Women already recruited for another trial on medically assisted procreation during the same cycle~* Women who have previously enrolled in the trial~* Those unable to comprehend the investigational nature of the proposed study

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 40 Years
- Healthy Volunteers: f

Study Arms:
- Control arm (Type: NO_INTERVENTION): Women undergoing exogenous gonadotropin ovarian stimulation for ART in an antagonist downregulated cycle.
- Induced endometrial injury arm (Type: EXPERIMENTAL): Women undergoing exogenous gonadotropin ovarian stimulation for ART in an antagonist downregulated cycle. Additionally, they will undergo an endometrial biopsy on the 6th day of ovarian stimulation using a Pipelle de Cornier® (CCD International, Paris, France).

Based on this trial design, predict the completion outcome and termination type (if applicable).